# § 522.2473   Tiludronate.

(a) *Specifications.* Each vial of powder contains 500 milligrams (mg) tiludronate disodium. Each milliliter of constituted solution contains 20 mg tiludronate disodium.


(b) *Sponsor.* See No. 061133 in § 510.600(c) of this chapter.


(c) *Conditions of use in horses*—(1) *Amount.* Administer a single dose of 1 mg per kilogram (0.45 mg/pound) of body weight by intravenous infusion.


(2) *Indication for use.* For the control of clinical signs associated with navicular syndrome.


(3) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [79 FR 18159, Apr. 1, 2014, as amended at 82 FR 21691, May 10, 2017; 84 FR 8974, Mar. 13, 2019]




